Y Intercept Hong Kong Ltd reduced its holdings in shares of EverQuote, Inc. (NASDAQ:EVER - Free Report) by 55.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,605 shares of the company's stock after selling 12,038 shares during the period. Y Intercept Hong Kong Ltd's holdings in EverQuote were worth $252,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently added to or reduced their stakes in the company. Jackson Creek Investment Advisors LLC acquired a new position in shares of EverQuote in the first quarter valued at about $1,523,000. Sigma Planning Corp purchased a new position in shares of EverQuote in the first quarter valued at approximately $289,000. CWM LLC lifted its position in shares of EverQuote by 124.3% in the first quarter. CWM LLC now owns 12,701 shares of the company's stock valued at $333,000 after acquiring an additional 7,038 shares in the last quarter. Emerald Advisers LLC purchased a new position in shares of EverQuote in the first quarter valued at approximately $11,621,000. Finally, Arizona State Retirement System purchased a new position in shares of EverQuote in the first quarter valued at approximately $202,000. 91.54% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other news, CEO Jayme Mendal sold 14,360 shares of EverQuote stock in a transaction on Monday, July 21st. The stock was sold at an average price of $24.87, for a total value of $357,133.20. Following the completion of the sale, the chief executive officer directly owned 527,140 shares of the company's stock, valued at approximately $13,109,971.80. The trade was a 2.65% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director John L. Shields sold 2,000 shares of EverQuote stock in a transaction on Monday, July 14th. The shares were sold at an average price of $24.30, for a total value of $48,600.00. Following the completion of the sale, the director directly owned 31,219 shares of the company's stock, valued at $758,621.70. The trade was a 6.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 63,162 shares of company stock valued at $1,524,781. Insiders own 29.79% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on EVER shares. Needham & Company LLC reissued a "buy" rating and set a $38.00 target price on shares of EverQuote in a research note on Tuesday, May 6th. JPMorgan Chase & Co. lifted their target price on EverQuote from $29.00 to $30.00 and gave the company an "overweight" rating in a research report on Tuesday, May 6th. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $32.50.
View Our Latest Stock Report on EVER
EverQuote Stock Performance
Shares of NASDAQ EVER traded down $0.49 during trading on Friday, reaching $24.10. The stock had a trading volume of 398,488 shares, compared to its average volume of 353,140. EverQuote, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $30.03. The business's 50-day moving average price is $24.53 and its 200-day moving average price is $23.74. The company has a market cap of $860.85 million, a P/E ratio of 23.63 and a beta of 0.37.
EverQuote Profile
(
Free Report)
EverQuote, Inc operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc, and changed its name to EverQuote, Inc in November 2014.
Featured Stories

Before you consider EverQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EverQuote wasn't on the list.
While EverQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.